Opko Health
OPK
218 hedge funds and large institutions have $259M invested in Opko Health in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 65 reducing their positions, and 32 closing their positions.
655% more call options, than puts
Call options by funds: $5.35M | Put options by funds: $708K
0.59% more ownership
Funds ownership: 21.63% → 22.22% (+0.59%)
3% less capital invested
Capital invested by funds: $268M → $259M (-$8.2M)
3% less funds holding
Funds holding: 225 → 218 (-7)
18% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 65
22% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.33M |
| 2 |
BlackRock
New York
|
+$3.19M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$2.4M |
| 4 |
Goldman Sachs
New York
|
+$1.06M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$2.19M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.95M |
| 3 |
Axa
Paris,
France
|
-$1.78M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.53M |
| 5 |
Renaissance Technologies
New York
|
-$1.29M |
OPK Hedge Fund Activity: Q4 2023 in Review
218 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q4 2023, worth a combined $259M — down 3.1% from $268M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of OPK and 25 opened new positions — a net loss of 7 holders — while 65 trimmed existing stakes and 53 added.
The largest buyer was Morgan Stanley, adding an estimated $3.33M. The largest seller was Nuveen, cutting an estimated $2.19M.
- 218 institutional investors held Opko Health (OPK) as of Q4 2023, down from 225 in Q3 2023.
- Funds reported $259M of Opko Health stock for Q4 2023, down 3.1% quarter-over-quarter.
- 25 funds opened new Opko Health positions in Q4 2023 and 32 closed out, a net change of -7 holders.
- The largest Opko Health buyer in Q4 2023 was Morgan Stanley, an estimated $3.33M added.
- The largest Opko Health seller in Q4 2023 was Nuveen, an estimated $2.19M sold.
Based on aggregated 13F filings for Q4 2023.